Interference with follicle stimulating hormone regulation of human ovarian function

Molecular Human Reproduction

Volumn 2, Issue 5, 1996, Pages 327-334

  Fauser, B C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Anti FSH; Bioactivity; Follicle development; FSH; Gonadotrophins

Indexed keywords

FOLLITROPIN; FOLLITROPIN RECEPTOR;

FEMALE; HUMAN; OVARY; PHYSIOLOGY; REVIEW;

FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; OVARY; RECEPTORS, FSH;

EID: 0030132583     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/2.5.327     Document Type: Article

References (93)

1. Aittomaki, K., Lucena, J.L., Pakarinen, P. et al. (1995) Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell, 82, 959-968.
2. Albaneset C., Christin-Maitre, S., Sluss, P. et al. (1994) Development of a bioassay for follicle-stimulating hormone using recombinant human FSH receptor and a cAMP responsive luciferase reporter gene. Mol. Cell. Endocrinol., 101, 211-219.
3. Aldhous, P. (1994) A booster for contraceptive vaccines. Science, 266, 1484-1486.
4. Anasti, J.N., Flack, M.R., Froehlich, J. and Nelson, L.M. (1995) The use of human recombinant gonadotropin receptors to search for immunoglobulin G-mediated premature ovarian failure. J. Clin. Endocrinol. Metab., 80, 824-828.
5. Bicsak, T.A., Ling, N. and DePaolo, L.V. (1991) Ovarian intrabursal administration of insulin-like growth factor-binding protein inhibits follicle rupture in gonadotropin-treated immature female rats. Biol. Reprod., 44, 599-603.
6. Bishop, L.A., Robertson, D.M., Cahir, N. and Schofield, P.R. (1994) Specific roles for the asparagine-linked carbohydrate residues of recombinant human FSH in receptor binding and signal transduction. Mol. Endocrinol., 8, 722-731.
7. Boime, I., Keene, J., Matzuk, M.M. et al. (1990) Expression of recombinant human FSH and LH in mammalian cells: a source of potential agonists and antagonists for controlling fertility. In Evers, J.H.L. and Heineman, M.J. (eds.), From Ovulation to Implantation. Elsevier Science Publishers, Amsterdam, pp. 23-34.
8. Boime, I., Keene, J., Galway, A.B. et al. (1992) Expression of recombinant human FSH, LH and CG in mammalian cells: a structure-function model for therapeutic drug design. Sem. Reprod. Endocrinol., 10, 45-50.
9. Catt, K.J. and Dufau, M.L. (1991) Gonadotropic hormones: biosynthesis, secretion, receptors and action. In Yen, S.S.C. and Jaffe, R.B. (eds.), Reproductive Endocrinology. Saunders, Philadelphia, pp. 105-155.
10. Cerpa-Poljak, A., Bishop, L.A., Hort, Y.J. et al. (1993) Isoelectric charge of recombinant human follicle-stimulating hormone isoforms determines receptor affinity and in vitro bioactivity. Endocrinology, 132, 351-356.
11. Chappel, S.C. (1995) Heterogeneity of follicle-stimulating hormone: control and physiological function. Hum. Reprod. Update, 1, 479-487.
12. Chiauzzi, V., Cigorraga, S., Escobar, M.E. et al. (1982) Inhibition of FSH receptor binding by circulating immunoglobulins. J. Clin. Endocrinol. Metab., 54, 1221-1228.
13. Combarnous, Y. (1992) Molecular basis of the specificity of binding of glycoprotein hormones to their receptors. Endocr. Rev., 13, 670-691.
14. Dahl, K.D., Pavlou, S.N., Kovacs, W.J. and Hsueh, A.J. (1986) The changing ratio of serum bioactive to immunoreactive follicle-stimulating hormone in normal men following treatment with a potent gonadotropin releasing hormone antagonist. J. Clin. Endocrinol. Metab., 63, 792-794.
15. Dahl, K.D., Bicsak, T.A. and Hsuch, A.J.W. (1988) Naturally occurring antihormones: secretion of FSH antagonists by women treated with a GnRH analog. Science, 239, 72-74.
16. Dahl, K.D., Jia, X.C. and Hsueh, A.J. (1989) Granulosa cell aromatase bioassay for follicle-stimulating hormone. Methods Enzymol., 168, 414-422.
17. Dattatreyamurty, B. and Reichert, L.E. (1992) A synthetic peptide corresponding to amino acids 9-30 of the extracellular domain of the FSH receptor specifically binds FSH. Mol. Cell. Endocrinol., 87, 9-17.
18. Dattatreyamurty, B., Schweder, C.A. and Reichert, L.E., Jr. (1994) Identification in human ovarian follicular fluid of proteins that share an epitope region unique to the extracellular domain of the follicle-stimulating hormone receptor. J. Clin. Endocrinol. Metab., 79, 1303-1309.
19. Dias, J.A. (1992) Recent progress in structure-function and molecular analyses of the pituitary/placental glycoprotein hormone receptors. Biochim. Biophys. Acta, 1135, 287-294.
20. Dias, J.A., Gates, S.A. and Reichert, L.E.J. (1982) Evidence for the presence of follicle-stimulating hormone receptor antibody in human serum. Fertil. Steril., 38, 330-338.
21. Fares, F.A., Suganuma, N., Nishimori, K. et al. (1992) Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit. Proc. Natl. Acad. Sci. USA, 89, 4304-4308.
22. Fauser, B.C.J.M. and Hsueh, A.J.W. (1988) Growth factors: intragonadal regulation of differentiated functions. In Imura, H., Shizume, K. and Yoshida, S. (eds.), Progress in Endocrinology. Elsevier Science Publishers, Amsterdam, pp. 451-456.
23. Fauser, B.C., Soto, D., Czekala, N.M. and Hsueh, A.J. (1989) Granulosa cell aromatase bioassay: changes of bioactive FSH levels in the female. J. Steroid Biochem., 33, 721-726.
24. Fauser, B.C., Donderwinkel, P. and School, D.C. (1993) The step-down principle in gonadotrophin treatment and the role of GnRH analogues. Baillières. Clin. Obstet. Gynaecol, 7, 309-330.
25. Fauser, B.C.J.M. and Hsueh, A.J.W. (1995) Genetic basis of human reproductive endocrine disorders. Hum. Reprod., 10, 826-846.
26. Flack, M.R., Bennet, A.P., Frochlich, J. et al. (1994) Increased biological activity due to basic isoforms in recombinant human follicle-stimulating hormone produced in a human cell line. J. Clin. Endocrinol. Metab., 79, 756-760.
27. Galway, A.B., Hsueh, A.J., Keene, J.L. et al. (1990) In vitro and in vivo bioactivity of recombinant human follicle-stimulating hormone and partially deglycosylated variants secreted by transfected eukaryotic cell lines. Endocrinology, 127, 93-100.
28. Gast, M.J. (1995) Evolution of clinical agents for ovulation induction. Am. J. Obstet. Gynecol, 172, 753-759.
29. Graves, P.N., Magnusson, R.P., Fing, P. and Davies, T.F. (1993) Identification of a TSH receptor variant protein lacking the transmembrane region in human serum. (Abstr. 355) In 75th Annual Meeting of the Endocrine Society, Las Vegas, USA.
30. Griffin, P.D. (1994) The WHO task force on vaccines for fertility regualion: its formation, objectives and research activities. Hum. Reprod., 9, 166-172.
31. Gromoll, J., Gudermann, T. and Nieschlag, E. (1992) Molecular cloning of a truncated isoform of the human follicle stimulating hormone receptor. Biochem. Biophys. Res Commun., 188, 1077-1083.
32. Hillier, S.G. and Miro, F. (1993) Inhibin, activin and follistatin. Potential roles in ovarian physiology. Ann. N.Y. Acad. Sci., 687, 29-38.
33. Hodgen, G.D. (1982) The dominant ovarian follicle. Fertil. Steril., 38, 281-300.
34. Jia, X.C. and Hsueh, A.J. (1986) Granulosa cell aromatase bioassay for follicle-stimulating hormone: validation and application of the method. Endocrinology, 119, 1570-1577.
35. Keene, J.L., Matzuk, M.M. and Boime, I. (1989) Expression of recombinant human CG in Chinese hamster ovary glycosylation mutants. Mol. Endocrinol., 3, 2011-2017.
36. Keene, J.L., Nishimori, K., Galway, A.B. et al. (1994) Recombinant deglycosylated human FSH is an antagonist of human FSH action in cultured rat granulosa cells. Endocr. J., 2, 175-180.
37. Kellon, C.A., Cheng, S.V., Nugent, N.P. et al. (1992) The cloning of the human follicle stimulating hormone receptor and its expression in COS-7, CHO and Y-1 cells. Mol. Cell Endocrinol., 89, 141-151.
38. Keutmann, H.T. (1992) Receptor-binding regions in human glycoprotein hormones. Mol. Cell. Endocrinol., 86, C 1 -C6.
39. Knecht, M. and Catt, K.J. (1983) Modulation of cAMP mediated differentiation in ovarian granulosa cells by epidermal growth factor and platelet derived growth factor. J. Biol. Chem., 258, 2789-2794.
40. LaPolt, P.S., Nishimori, K., Fares, F.A. et al. (1992) Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides. Endocrinology, 131, 2514-2520.
41. Lee, D.W., Shelden, R.M. and Reichert, L.E.J. (1990) Identification of low and high molecular weight follicle-stimulating hormone receptor-binding inhibitors in human follicular fluid. Fertil. Steril., 53, 830-835.
42. Lee, D.W., Butler, W.J., Horvath, P.M. et al. (1991) Human follicular fluid contains a follicle-stimulating hormone (FSH) receptor binding inhibitor which has FSH agonist activity, is immunologically similar to FSH, but can be distinguished from FSH. J. Clin. Endocrinol. Metab., 72, 1102-1107.
43. Lee, D.W., Grasso, P., Dattatreyamurty, B. et al. (1993) Purification of a high molecular weight follicle-stimulating hormone receptor-binding inhibitor from human follicular fluid. J. Clin. Endocrinol. Metab., 77, 163-168.
44. Leung, D.W., Spencer, S.A. and Cachianes, G. (1987) Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature, 330, 537-743.
45. Ling, N., Ui, M., Shimonaka, M. et al. (1990) An IGF-binding protein in ovarian follicular fluid blocks FSH-stimulated steroid production by ovarian granulosa cells. In Yen, S.S.C. and Vale, W.W. (eds), Neuroendocrine Regulation of Reproduction. Serono Symposia Series, Norwell, pp. 207-215.
46. Loumaye, E., Campbell, R. and Salat-Baroux, J. (1995) Human follicle stimulating hormone produced by recombinant DNA technology: a review for clinicians. Hum. Reprod. Update, 1, 188-199.
47. Mason, H.D., Margara, R., Winston, R.M. et al. (1990) Inhibition of oestradiol production by epidermal growth factor in human granulosa cells of normal and polycystic ovaries. Clin. Endocrinol., 33, 511-517.
48. Mason, M., Fonseca, E., Ruiz, J.E. et al. (1992a) Distribution of 2 follicle-stimulating hormone and luteinizing hormone isoforms in sera from women with primary ovarian failure compared with that of normal reproductive and postmenopausal women. Fertil. Steril., 58, 60-65.
49. Mason, H.D., Willis, D., Holly, J.M. et al. (1992b) Inhibitory effects of insulin-like growth factor-binding proteins on steroidogenesis by human granulosa cells in culture. Mol. Cell Endocrinol., 89, R1-R4.
50. Mason, H.D., Margara, R., Winston, R.M. et al. (1993) Insulin-like growth factor-I (IGF-1) inhibits production of IGF-binding protein-1 while stimulating estradiol secretion in granulosa cells from normal and polycystic human ovaries. J. Clin. Endocrinol. Metab., 76, 1275-1279.
51. McNatty, K.P., Smith, P., Hudson, N.L. et al. (1992) Follicular development and steroidogenesis. In Sjoberg, N.O., Hamberger, L., Janson, P.O. et al. (eds), Local Regulation of Ovarian Function. Parthenon Publishing, Carnforth, UK, pp. 21-38.
52. Meyer, W.R., Lavy, G., DeCherney, A.H. et al. (1990) Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet. Gynecol., 75, 795-799.
53. Miro, F. and Hillier, S.G. (1992) Relative effects of activin and inhibin on steroid hormone synthesis in primate granulosa cells. J. Clin. Endocrinol. Metab., 75, 1556-1561.
54. Moudgal, N.R., Ravindranath, N., Murthy, G.S. et al. (1992) Long-term contraceptive efficacy of vaccine of ovine follicle-stimulating hormone in male bonnet monkeys (Macaca radiata). J. Reprod. Fertil., 96, 91-102.
55. Murthy, G.S., Sheela Rani, C.S., Moudgal, N.R. and Prasad, M.R. (1979) Effect of passive immunization with specific antiserum to FSH on spermatogenic process and fertility of adult male bonnet monkeys (Macaca radiata). J. Reprod. Fertil., 16 (Suppl.), 147-163.
56. Ono, T., Campeau, J.D., Holmberg, E.A. et al. (1986) Biochemical and biophysical characterization of follicle regulatory protein: a paracrine regulator of folliculogenesis. Am. J. Obstet. Gynecol., 154, 709-716.
57. Out, H.J., Mannaerts, B.M., Driessen, S.G. and Coelingh Bennink, H.J. (1995) A prospective, randomized, assessor blind, multicenter study comparing recombinant and urinary follicle-stimulating hormone in in-vitro fertilization. Hum. Reprod., 10, 2534-2540.
58. Padmanabhan, V., Lang, L.L., Sonstein, J. et al. (1988) Modulation of serum FSH bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis. J. Clin. Endocrinol. Metab., 67, 465-473.
59. Pezzino, V., Papa, V. and Constantino, A. (1992) Identification and initial charcterization of insulin-receptor like immunoreactivity in human plasma. J. Clin. Endocrinol. Metab., 74, 1116-1121.
60. Platia, M.P., Bloomquist, G., Williams, R.F. and Hodgen, G.D. (1984) Refractoriness to gonadotropin therapy: how to distinguish between ovarian failure versus pseudoovarian resistance caused by neutralizing antibodies. Fertil. Steril., 42, 779-784.
61. Recombinant human FSH study group (1995) Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil. Steril., 63, 77-86.
62. Reichert, L.E., Sanzo, M.A. and Darga, N.S. (1979) Studies on a low molecular weight follicle-stimulating hormone binding inhibitor from human serum. J. Clin. Endocrinol. Metab., 49, 866-872.
63. Reichert, L.E. (1994) The functional relationship between FSH and its receptor as studied by synthetic peptide strategies. Mol. Cell. Endocrinol., 199, 21-27.
64. Santa Coloma, T.A. and Reichert, L.E. (1990) Identification of a FSH receptor-binding region in hFSH-β-(81-95) using synthetic peptides. J. Biol. Chem., 265, 5037-5042.
65. Santo Coloma, T.A., Dattatreyamurty, B. and Reichert, L.E. (1990) A synthetic peptide corresponding to human FSH β-subunit 33-53 binds to FSH receptor, stimulates basal estradiol biosynthesis and is a partial antagonist of FSH. Biochemistry, 29, 1194-1200.
66. Santa Coloma, T.A., Crabb, J.W. and Reichert, L.E. (1992) Serine analogues of hFSH-beta-(33-53) and hFSH-beta-(81-95) inhibit hFSH binding to receptor. Biochem. Biophys. Res. Commun., 184, 1273-1279.
67. Sanzo, M.A. and Reichert, L.E. (1982) Gonadotropin receptor binding regulators in serum. J. Biol. Chem., 257, 6033-6040.
68. Schipper, I., Fauser, B.C., ten Hakken, P.M. and Rommerts, F.F. (1995) No specific inhibitors of FSH receptor activation in human serum. (Abstr. P1-117) in 77th annual meeting of the Endocrine Society, Washington DC, USA.
69. Schneyer, A.L., Sluss, P.M., Whitcomb, R.W. et al. (1991) Precursors of alpha-inhibin modulate follicle-stimulating hormone receptor binding and biological activity. Endocrinology, 129, 1987-1999.
70. Schoot, D.C., Harlins J., Shoham, Z. et al. (1994) Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum. Reprod., 9, 1237-1249.
71. Sheela Rani, C.S., Murthy, G.S. and Moudgal, N.R. (1978) Effect of chronic neutralization of endogenous FSH on testicular function in the adult male bonnet monkey. Int. J. Androl., 1, 489-500.
72. Shimasaki, S., Shimonaka, M., Ui, M. et al. (1990) Structural characterization of a follicle-stimulating hormone action inhibitor in porcine ovarian follicular fluid. Its identification as the insulin-like growth factor-binding protein. J. Biol. Chem., 265, 2198-2202.
73. Sluss, P.M. and Schneyer, A.L. (1992) Low molecular weight follicle-stimulating hormone receptor binding inhibitor in sera from premature ovarian failure patients. J. Clin. Endocrinol. Metab., 74, 1242-1246.
74. Spitz, I., Bell, J., Arad, G. et al. (1973) Development of anti human FSH antibody in a patient with isolated FSH deficiency. J. Clin. Endocrinol. Metab., 36, 684-690.
75. Srinath, B.R., Wickings, E.J., Witting, C. and Nieschlag, E. (1983) Active immunization with follicle-stimulating hormone for fertility control: a 4 1/2-year study in male rhesus monkeys. Fertil. Steril., 40, 110-117.
76. Stanton, P.G., Robertson, D.M., Burgon, P.G. et al. (1992) Isolation and physiochemical characterization of human FSH isoforms. Endocrinology, 130, 2820-2832.
77. Steinkampf, M.P., Mendelson, C.R. and Simpson, E.R. (1988) Effects of epidermal growth factor and insulin-like growth factor I on the level of mRNA encoding aromatase cytochrome P-450 of human ovarian granulosa cells. Mol. Cell. Endocrinol., 59, 93-99.
78. Sugahara, T., Pixley, M.R., Minami, S. et al. (1995) Biosynthesis of a biologically active single peptide chain containing the human common alpha and chorionic gonadotropin beta subunits in tandem. Proc. Natl. Acad. Sci. USA, 92, 2041-2045.
79. Tang, V.W. and Faiman, C. (1983) Premature ovarian failure: a search for circulating factors against gonadotropin receptors. Am. J. Obstet. Gynecol., 146, 816-821.
80. Tapanainen, J.S., Bo, M., Dunkel, L. et al. (1993) Deglycosylation of the human LH receptor does not affect ligand binding and signal transduction. Endocr. J., 1, 219-225.
81. Themmen, A.P. and Grootegoed, J.A. (1994) Regulation of gonadotropin receptor gene expression. Mol. Cell. Endocrinol., 100, 15-19.
82. Tilly, J.L., Aihara, T., Nishimori, K. et al. (1992) Expression of recombinant human follicle-stimulating hormone receptor: species-specific ligand binding, signal transduction and identification of multiple ovarian messenger ribonucleic acid transcripts. Endocrinology, 131, 799-806.
83. Tsai-Morris, C.H., Buczko, E., Wang, W. and Dufau, M.L. (1990) Intronic nature of the rat LH receptor gene defines a soluble receptor species with hormone binding activity. J. Biol. Chem., 265, 19385-19388.
84. Ui, M., Shimonaka, M., Shimasaki, S. and Ling, N. (1989) An insulin-like growth factor-binding protein in ovarian follicular fluid blocks follicle-stimulating hormone-stimulated steroid production by ovarian granulosa cells. Endocrinology, 125, 912-916.
85. Ulloa-Aguirre, A., Cravioto, A., Damian-Matsumura, P. et al. (1992) Biological characterization of the naturally occurring analogues of intrapituitary human follicle-stimulating hormone. Hum. Reprod., 7, 23-30.
86. van Dessel, H.J.H.M., Schipper, I., Pache, T.D. et al. (1996a) Normal human follicle development: an evaluation of correlations with oestradiol androstenedione and progesterone levels in individual follicles. Clin. Endocrinol., 44, 191-198.
87. van Dessel, H.J.H.M., Chandrasekher, Y.A., Yap, S.O. et al. (1996b) Serum and ovarian follicle fluid levels of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 and -3 during the normal menstrual cycle support an auto/ paracrine role for the intraovarian IGF system. J. Clin. Endocrinol. Metab., 81, 1224-1231.
88. van Santbrink, E.J.P., van Dessel, H.J.H.M., Hop, W.C. et al. (1995) Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil. Steril., 64, 37-43.
89. Van Weissenbruch, M.M., Hoek, A., van Vliet-Bleeker, I. et al. (1991) Evidence for existence of immunoglobulins that block ovarian granulosa cell growth in vitro. A putative role in resistant ovary syndrome? J. Clin. Endocrinol. Metab., 73, 360-367.
90. Westergaard, L.G. (1992) Follicular atresia in the human ovary. In Sjoberg, N.O., Hamberger, L., Janson, P.O. et al. (eds). Local Regulation of Ovarian Function. Parthenon Publishing, Camforth, UK, pp. 55-64.
91. Whitney, E.A., Layman, L.C., Chan, P.J. et al. (1995) The follicle-stimulating hormone receptor gene is polymorphic in premature ovarian failure and normal controls. Fertil. Steril., 64, 518-524.
92. Wickings, E.J. and Nieschlag, E. (1980) Suppression of spermatogenesis over 2 years in rhesus monkeys actively immunized with follicle-stimulating hormone. Fertil. Steril., 34, 269-274.
93. Zambrano, E., Olivares, A., Mendez, J.P. et al. (1995) Dynamics of basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution throughout the human menstrual cycle. J. Clin. Endocrinol. Metab., 80, 1647-1656.